Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others
   Cell adhesion molecules (CAMs)
     CD2 [HSA:914] [KO:K06449]
     CD4 [HSA:920] [KO:K06454]
     integrin alpha4/beta1 [HSA:3676 3688] [KO:K06483 K05719]
     integrin alpha4/beta7 [HSA:3676 3695] [KO:K06483 K06590]
     integrin alpha5/beta1 (VLA-5) [HSA:3678 3688] [KO:K06484 K05719]
       Volociximab
         D06319  Volociximab (USAN)
Monoclonal antibody
     integrin alphav/beta3 (VNR) [HSA:3685 3690] [KO:K06487 K06493]
     integrin alphav/beta5 [HSA:3685 3693] [KO:K06487 K06588]
     integrin alphaE/beta7 [HSA:3682 3695] [KO:K06524 K06590]
     LFA-1 (CD11A / CD18) [HSA:3683 3689]
     CR3 (CD11B / CD18) [HSA:3684 3689] [KO:K06461 K06464]
     glycoprotein alpha IIb/beta3 (GPIIb/IIIa) receptor [HSA:3674 3690] [KO:K06476 K06493]
     delta-like 4 (DLL4) [HSA:54567] [KO:K06051]
   Cellular antigens
   Toll-like receptors
   T-cell co-receptor
   Glycan binding proteins
   Heparin binding proteins
   Lipid transfer proteins
   Cytoskeleton proteins
   SNARE proteins
   Antibodies
   Complement system
   Inhibitors of apoptosis (IAP) protein family
   Nucleic acid

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 22, 2014

» Japanese version